FDA committee to discuss adverse effects of testosterone products

July 17, 2014 6:39 PM

6 0

FDA committee to discuss adverse effects of testosterone products

The 3D printing revolution

(Reuters) - The U.S. Food and Drug Administration has called an advisory committee meeting on Sept. 17, to discuss the adverse cardiovascular outcomes with the usage of testosterone replacement therapy.

Also read: FDA approves Newron's drug as add-on therapy for Parkinson's

Read more

To category page

Loading...